Annexon (ANNX) Amortizatization of Intangibles (2021 - 2026)

Annexon's (ANNX) quarterly Amortizatization of Intangibles came in at $632000.0 in Q1 2026, down 65.84% year-on-year from $1.8 million in Q1 2025, and up 49.06% quarter-over-quarter from $424000.0 in Q4 2025.

Annexon (ANNX) Amortizatization of Intangibles (2021 - 2026) Analysis & Trends

Annexon's Amortizatization of Intangibles history runs 6 years deep, the most recent figure standing at $632000.0 for Q1 2026.

  • On a quarterly basis, Amortizatization of Intangibles fell 65.84% year-over-year to $632000.0 in Q1 2026; TTM through Mar 2026 was $2.8 million, a 71.47% decrease from a year earlier, with the FY2025 full-year figure at $4.0 million, down 55.77% from the prior year.
  • Amortizatization of Intangibles rose to $632000.0 in Q1 2026 per ANNX's latest filing, from $424000.0 in the prior quarter.
  • Across five years, Amortizatization of Intangibles topped out at $3.1 million in Q3 2024 and bottomed at -$380000.0 in Q1 2022.
  • The 5-year median for Amortizatization of Intangibles is $632000.0 (2026), against an average of $951058.8.
  • Across the five-year window, Amortizatization of Intangibles plunged 111.11% in 2022 and soared 1062.31% in 2024, its largest moves.
  • Year by year, Amortizatization of Intangibles stood at $417000.0 in 2022, then plunged by 37.65% to $260000.0 in 2023, then surged by 1062.31% to $3.0 million in 2024, then slumped by 85.97% to $424000.0 in 2025, then soared by 49.06% to $632000.0 in 2026.
  • Per Business Quant, the three latest ANNX Amortizatization of Intangibles figures stand at $632000.0 (Q1 2026), $424000.0 (Q4 2025), and $475000.0 (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Amortizatization of Intangibles (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn - -
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn -
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn -
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn -
7 Belite Bio 61.40 Bn 61.40 Bn - -
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn -
9 Revolution Medicines 37.37 Bn 37.37 Bn - 3.22 Mn
10 Annexon 1.02 Bn 798.41 Mn - 632,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 632,000.00
Mar 31, 2026 632,000.00
Dec 31, 2025 424,000.00
Dec 31, 2025 424,000.00
Sep 30, 2025 475,000.00
Sep 30, 2025 475,000.00
Jun 30, 2025 1.26 Mn
Jun 30, 2025 1.26 Mn
Mar 31, 2025 1.85 Mn
Mar 31, 2025 1.85 Mn
Dec 31, 2024 3.02 Mn
Dec 31, 2024 3.02 Mn
Sep 30, 2024 3.10 Mn
Sep 30, 2024 3.10 Mn
Jun 30, 2024 1.80 Mn
Jun 30, 2024 1.80 Mn
Mar 31, 2024 1.14 Mn
Mar 31, 2024 1.14 Mn
Dec 31, 2023 260,000.00
Dec 31, 2023 260,000.00